$Aeglea BioTherapeutics, Inc.(AGLE)$ 8-K - Current report Filed: 2018-03-13 AccNo: 0001564590-18-005402 Size: 285 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接